ABBV vs LLY: Valuation Comparison 2026
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Side-by-side fundamentals for AbbVie Inc. (ABBV) and ELI LILLY & Co (LLY) — market cap, PE, PEG and sector. All figures from SEC filings and market data.
| Metric | ABBV | LLY |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Current Price (Cboe, delayed) | $257.12 | $1,115.7 |
| Market Cap | $454.36B | $1.05T |
| PE Ratio | 72.43 | 37.38 |
| PEG Ratio | — | 1.36 |
| PEG Verdict | N/A | PEG 1.0–2.0 |